300 related articles for article (PubMed ID: 33802402)
1. Mucosa-Associated Lymphoid Tissue 1 Is an Oncogene Inducing Cell Proliferation, Invasion, and Tumor Growth via the Upregulation of NF-κB Activity in Human Prostate Carcinoma Cells.
Tsui KH; Chang KS; Sung HC; Hsu SY; Lin YH; Hou CP; Yang PS; Chen CL; Feng TH; Juang HH
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33802402
[TBL] [Abstract][Full Text] [Related]
2. Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells.
Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047218
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Effect of Caffeic Acid Phenethyl Ester by Downregulating Mucosa-Associated Lymphoid Tissue 1 via AR/p53/NF-κB Signaling in Prostate Carcinoma Cells.
Chang KS; Tsui KH; Hsu SY; Sung HC; Lin YH; Hou CP; Yang PS; Chen CL; Feng TH; Juang HH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053438
[TBL] [Abstract][Full Text] [Related]
4. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
[TBL] [Abstract][Full Text] [Related]
5. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
Afonina IS; Elton L; Carpentier I; Beyaert R
FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
[TBL] [Abstract][Full Text] [Related]
6. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
7. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
8. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
[TBL] [Abstract][Full Text] [Related]
9. Halting Multiple Myeloma with MALT1 Inhibition: Suppressing BCMA-Induced NF-κB and Inducing Immunogenic Cell Death.
Yao Y; Yuan M; Shi M; Li W; Sha Y; Zhang Y; Yuan C; Luo J; Li Z; Liao C; Xu K; Mingshan N
Blood Adv; 2024 May; ():. PubMed ID: 38820414
[TBL] [Abstract][Full Text] [Related]
10. MALT1 promotes melanoma progression through JNK/c-Jun signaling.
Wang Y; Zhang G; Jin J; Degan S; Tameze Y; Zhang JY
Oncogenesis; 2017 Jul; 6(7):e365. PubMed ID: 28759024
[TBL] [Abstract][Full Text] [Related]
11. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
12. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
[TBL] [Abstract][Full Text] [Related]
13. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
14. MALT1 accelerates proatherogenic vascular smooth muscle cell growth, invasion and synthetic phenotype switching via nuclear factor‑κB signaling‑dependent way.
Zheng H; Bai L
Exp Ther Med; 2023 Jul; 26(1):337. PubMed ID: 37383381
[TBL] [Abstract][Full Text] [Related]
15. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
Wang Y; Liu Z; Zhang M; Yu B; Ai F
Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
[TBL] [Abstract][Full Text] [Related]
17. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
[TBL] [Abstract][Full Text] [Related]
18. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
Nicolau CA; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
[TBL] [Abstract][Full Text] [Related]
19. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
Hosokawa Y; Suzuki H; Nakagawa M; Lee TH; Seto M
Biochem Biophys Res Commun; 2005 Aug; 334(1):51-60. PubMed ID: 15982633
[TBL] [Abstract][Full Text] [Related]
20. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
Coornaert B; Baens M; Heyninck K; Bekaert T; Haegman M; Staal J; Sun L; Chen ZJ; Marynen P; Beyaert R
Nat Immunol; 2008 Mar; 9(3):263-71. PubMed ID: 18223652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
